NSC |
Compound |
Enrichment |
Correlation |
NSC 145669 |
4(1H)-Quinazolinone, 2,3-dihydro-2-(1-naphthalenyl)- (9CI) |
0.0133012546828914 |
0.35631305 |
NSC 269719 |
Estr-4-en-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (17.beta.)- |
0.0133012546828914 |
0.39431419 |
NSC 29459 |
Quinoline, 4-[.alpha.-[bis(2-chloroethyl)amino]-4-methoxy-m-toluidino]-7-chloro-, dihydrochloride |
0.0133012546828914 |
0.4310899 |
NSC 370875 |
Null |
0.0133012546828914 |
0.22465372 |
NSC 623794 |
1,4-Benzodioxin-2-carboxamide, 6-(4-oxo-4-H-1- benzopyran-2-yl)-N-(3-pyridinylmethyl)- |
0.0137568419586474 |
0.046588294 |
NSC 685272 |
D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone |
0.0137568419586474 |
0.067914183 |
NSC 705584 |
Null |
0.0137568419586474 |
0.16621873 |
NSC 3060 |
Arsenenous acid, potassium salt (9CI) |
0.0137568419586476 |
0.26080036 |
NSC 724784 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 |
0.0140620887790591 |
0.12955997 |
NSC 628906 |
3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Trifluoroacetate. |
0.0186200143729973 |
0.16618366 |